R. Caccaro

发表

P.15.8 ASSESSMENT OF BOWEL PREPARATION FOR COLONOSCOPY: COMPARISON BETWEEN DIFFERENT TOOLS AND DIFFERENT HEALTHCARE PROFESSIONALS

F. Marzari, R. D'Incà, G. Sturniolo, 2013 .

Prevalence, Pathogenesis and Management of Anemia in Inflammatory Bowel Disease: An IG-IBD Multicenter, Prospective, and Observational Study.

P. Gionchetti, F. Rizzello, G. Fiorino, 2022, Inflammatory bowel diseases.

Fecal lactoferrin and intestinal permeability are effective non-invasive markers in the diagnostic work-up of chronic diarrhea

A. Frigo, R. D'Incà, G. Sturniolo, 2014, BioMetals.

Factors associated with disability in patients with ulcerative colitis: A cross‐sectional study

E. Savarino, C. Marinelli, R. D'Incà, 2019, Journal of digestive diseases.

Improving IBD diagnosis and monitoring by understanding preanalytical, analytical and biological fecal calprotectin variability

M. Rugge, M. Plebani, R. D'Incà, 2018, Clinical chemistry and laboratory medicine.

A case of anorexia nervosa with comorbid Crohn's disease: beneficial effects of anti-TNF-α therapy?

M. Solmi, P. Santonastaso, A. Favaro, 2013, The International journal of eating disorders.

Relevance of fecal calprotectin and lactoferrin in the post-operative management of inflammatory bowel diseases.

R. D'Incà, I. Angriman, R. Caccaro, 2016, World journal of gastrointestinal surgery.

Effectiveness of adalimumab for ulcerative colitis: A multicentre, retrospective study of clinical practice in Italy.

P. Gionchetti, F. Rizzello, M. Grova, 2021, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Safety and efficacy of Adalimumab for the induction of remission in Crohnʼs Disease in a specialist nurse lead outpatient clinic: Preliminary data from a single centre prospective study: P-0119.

G. Sturniolo, M. Martinato, L. Oliva, 2009 .

Clinical utility of calprotectin and lactoferrin in patients with inflammatory bowel disease: is there something new from the literature?

Surajit Pathak, R. D'Incà, G. Sturniolo, 2012, Expert review of clinical immunology.

Clinical, endoscopic, histological and radiological characteristics of Italian patients with eosinophilic oesophagitis.

E. Savarino, F. Galeazzi, M. Costantini, 2015, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Adalimumab for the prevention of recurrence after surgery for Crohn’s disease: author’s reply

E. Savarino, V. Savarino, R. Caccaro, 2012 .

Measuring disease activity in Crohn’s disease: what is currently available to the clinician

R. D'Incà, R. Caccaro, 2014, Clinical and experimental gastroenterology.

W1213 Determination of 5-ASA and Its Derivatives in the Colonic Mucosa of Ulcerative Colitis Patients: A Surrogate Marker of Oxidative Damage?

R. D'Incà, G. Sturniolo, M. Martinato, 2009 .

DETERMINATION OF 5-ASA AND ITS DERIVATIVES IN THE COLONIC MUCOSA OF ULCERATIVE COLITIS PATIENTS: A SURROGATE MARKER OF OXIDATIVE DAMAGE?

R. D'Incà, G. Sturniolo, M. Martinato, 2009 .

Clinical utility of calprotectin and lactoferrin as markers of inflammation in patients with inflammatory bowel disease

R. D'Incà, G. Sturniolo, R. Caccaro, 2010, Expert review of clinical immunology.

Fecal lactoferrin and intestinal permeability are effective non-invasive markers in the diagnostic work-up of chronic diarrhea

A. Frigo, R. D'Incà, G. Sturniolo, 2014, BioMetals.

A nurse-led accelerated procedure for infliximab infusion is well tolerated and effective in patients with inflammatory bowel disease.

R. D'Incà, G. Sturniolo, M. Martinato, 2015, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

The GerdQ questionnaire and high resolution manometry support the hypothesis that proton pump inhibitor‐responsive oesophageal eosinophilia is a GERD‐related phenomenon

E. Savarino, F. Galeazzi, M. Costantini, 2016, Alimentary pharmacology & therapeutics.

Black Esophagus: Acute Esophageal Necrosis

G. Portale, V. Fiscon, R. Caccaro, 2022, Indian Journal of Surgery.

OP005 The PROSIT cohort of infliximab biosimilar in IBD: a prolonged follow-up on the efficacy and safety across Italy.

A. Andriulli, V. Annese, A. Amato, 2017, Journal of Crohn's & colitis.

Noninfectious interstitial lung disease during infliximab therapy: case report and literature review.

E. Savarino, R. D'Incà, G. Sturniolo, 2013, World journal of gastroenterology.

P.07.3 EFFECTIVENESS OF GOLIMUMAB IN REAL LIFE – A SINGLE CENTER PROSPECTIVE STUDY

E. Savarino, C. Marinelli, B. Barberio, 2018 .

A case of anorexia nervosa with comorbid Crohn's disease: beneficial effects of anti-TNF-α therapy?

M. Solmi, P. Santonastaso, A. Favaro, 2013, International Journal of Eating Disorders.

Follow-up evaluation and management of anemia in inflammatory bowel disease: A study by the Italian Group for Inflammatory Bowel Diseases (IG-IBD).

P. Gionchetti, F. Rizzello, G. Fiorino, 2024, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.